CHAPTER ONE: INTRODUCTION

1.1 Background of SIWES

The Students Industrial Work Experience Scheme (SIWES) was established by the

Industrial Training Fund (ITF) in 1973 to address the severe shortage of practical

laboratory and engineering skills among Nigerian university graduates. It serves as a

mandatory academic bridge designed to transition students from theoretical biological

or chemical science models into concrete, real-world industrial and clinical

workplaces. Through this scheme, students test textbook assertions on automated

machinery, experience workplace group dynamics, and acquire specialized diagnostic

skills that cannot be taught in a standard classroom [Link] student industrial work

experience scheme is a mandatory program designed to bridge the gap between

theoretical knowledge acquired in professional workplace . as a student of

Biochemistry, this program offers an essential opportunity to apply principles of

molecular biology. Enzymology, and analytical chemistry to real-world clinical

challenges. Initially, the SIWES was solely funded by ITF,but due to financial

constraints, the Federal Government took over management in 1978, and later, in

1985 ITF resumed control with government fund. The scheme involves universities,

polytechnics , and colleges of educations, with over 200 participating institution.

1.2 Aims and Objectives of SIWES.

The Student Industrial Work Experience (SIWES) is a program in Nigeria that bridge

the gap between theoretical knowledge and practical skills in Nigeria tertiary

institutions.

Aim:

1
The main aim of the Student Industrial Work Experience (SIWES) is to equip student

with essential skills and prepare them for the demands of the actual workplace

through industry exposure.

Objectives:

 Bridging the Theory-Practice Gap: in this case, the students are provided

with an avenue to apply academic knowledge in real-world work situations.

 Industrial Skill Acquisition: exposing the students to modern work methods,

techniques, and the handling of equipment/machinery that are typically

unavailable in their school.

 Workplace Preparedness: Preparing student for the realities of the industrial

work environment they will face post- graduate.

 Facilitating Employment: Easing transition from school to the labour market

by creating valuable professional contacts and network opportunities for future

job placements.

 Stakeholder Integration: Strengthening the involvement of the educational

process to ensure graduates meet industry requirement.

 National Development: promoting the technological know-how required for

the economic and industrial advancement of Nigeria.

1.3 Profile of the Organization:

1.3.1 History of the organization:

The six months Student Industrial Work Experience Scheme was undertaken at Yobe

State Specialist Hospital Gashua, a specialized tertiary healthcare center located at

………the hospital was established in;;;;;;;; . With the vision to provide quantitative,

accessible, and affordable healthcare services. The hospital features dedicated

inpatient wards, emergency care units, surgical suites, and a pathology complex. The

2
institution provides intensive medical care to a broad demographic, making its

diagnostic infrastructure highly active and varied.

1.3.2 Departments/Units in the Organization

The organization comprises various specialized departments working synergistically

to provide comprehensive healthcare and diagnostic services. This includes:

 Chemical Pathology (Biochemistry Laboratory): Responsible for

evaluating body fluid to monitor organ function and diagnose metabolic

pathologies.

 Infection Prevention and Control (IPC) Unit: Focused on preventing

hospital-acquired infections through surveillance and, sanitation protocols ,

safety measures, as well as producing disinfectants.

 Hematology and Blood Transfusion unit: This unit deals with blood

counts, coagulation, profiles, and cross-matching.

 Medical Microbiology: Focused on the isolation and identification of

pathogenic microorganisms.

1.4 Organizational Structure

The administrative hierarchy ensures smooth operational flow from top management

down to trainees: below is the organizational structure of the organization.

3
 Chief Medical
Director

Head of Medical
Laboratory
Services

Head of Clinical
Head of IPC Unit
Biochemistry

Laboratory
Scientists/ IPC Officers/Staffs
Technologists

SIWES Trainee

1.5 Units of Attachment and Rotation Summary

The student's training schedule was strategically divided into two core operational

zones:

1. The Clinical Biochemistry Laboratory: Focused on processing metabolic

panels, quality control calibration, serum isolation, and kinetic enzymatic assays using

automated and semi-automated spectrophotometers.

2. The Infection Prevention and Control (IPC) Unit: Focused on

epidemiological surveillance, stopping the chain of nosocomial (hospital-acquired)

infections, preparing chemical disinfectants, and monitoring waste streaming.

4
CHAPTER TWO: THE CHEMICAL PATHOLOGY UNIT
(CLINICAL BIOCHEMISTRY APPLICATION).

INTRODUCTION TO CHEMICAL PATHOLOGY

A chemical pathology laboratory (also know as clinical biochemistry) is a

specialized diagnostic medical laboratory where automated analytical techniques are

used to analyze biological fluids primarily blood , serum, plasma, and urine- to assist

in the diagnosis, treatment, and monitoring of diseases by measuring the

concentration of various chemical substances , enzymes, protein, and hormones ,

these laboratory provides clinicians with critical data to evaluate organ function and

metabolic health. At the hearth of this discipline lies Enzyme assay, it is a powerful

and most important analytical tool that serves as the bridge between basic

biochemistry and clinical diagnostics. In the clinical laboratory, enzyme assay s are

not merely experimental procedures; they are vital diagnostic indicators. Unlike the

quantification of inert metabolites- such as Urea or Electrolytes - enzyme assays

quantify the catalytic activity of biological proteins. Because enzyme are primarily

intracellular components, their presence in extracellular fluids, such as serum or

plasma, serves as a biochemical maker of cellular integrity.

The diagnostic utility of these assays is rooted in two key biochemical

concepts:

i. Tissue specificity: Many enzymes exhibit organ-specific distribution

(isoenzyme). consequently, the measurement of specific enzyme activities allows

5
 clinicians to localize tissue damage, distinguishing between pathologies such as

myocardinal infection, hepatocellular injury, or bone turnover.

ii. Kinetic sensitivity: Enzyme assays, particularly those utilizing kinetic

monitoring, can detec metabolic dysfunction at an early stage. By measuring the

extent of disease activity in real-time.

2.1 Overview of Enzyme Assay in Disease Diagnosis:

An enzyme assay is a laboratory procedure designed to measure the catalytic

activity of an enzyme in a biological sample. In chemical pathology, this is the

primary way we determine if an organ is damaged, as enzyme are essentially the

"workers" inside our cells. When those cells are damaged or die, they spoil their

enzyme into the bloodstream, where we can detect and quntify them. Diagnostic

enzymology serves as a fundamental discipline within clinical biochemistry, utilizing

specialized quantitative methods to evaluate cellular damage, systemic metabolic anomalies,

and organ malfunction. Under physiological homeostatic conditions, intracellular enzymes

function as highly specialized catalysts. They lower the activation energy of

intracellular biochemical transformations, accelerating metabolic fluxes by multiple

orders of magnitude. These enzymes are structurally localized within specific

intracellular sub-compartments, bound by semi-permeable phospholipid bilayers. Due

to their high molecular weight and specialized function, the physiological rate of

active transport or passive leakage across cell membranes into extracellular fluid is

low. Consequently, baseline plasma or serum enzyme concentrations remain at tightly

regulated trace levels. The operational logic of an enzyme assay involves the

translation of structural cellular degradation into measurable analytical parameters. A

core biochemical concept in clinical enzymology is the classification of enzymes in

circulation.

6
We divide them into Functional and Non-Functional plasma enzymes.

a) Functional enzymes: Are synthesized by organs like the liver and actively

secreted into the blood to carry out physiological processes, such as coagulation.

When their levels are abnormally low, it indicates a tissue synthesis failure, such

as advanced liver cirrhosis. On the other hand,

b) Non-functional enzymes: These belong inside tissue cells. Normally, their

baseline levels in serum are very low, resulting only from routine physiological

cell turnover. However, when tissues are damaged by disease, physical trauma, or

hypoxia, these cells rupture and spill their contents. Therefore, a marked

elevation in nonfunctional enzyme activity acts as a direct diagnostic warning

sign of localized tissue damage.

Clinical assays evaluate the catalytic rate of an enzyme rather than its

mass concentration. This measurement is achieved by monitoring chemical

kinetics under strictly standardized, zero-order reaction conditions. At this

thermodynamic stage, the concentration of the chosen substrate is maintained in

excess, typically exceeding the Michaelis constant (Km) by a factor of ten or

more. This saturation ensures that the initial velocity (Vₒ) of the reaction operates

at its absolute maximum (Vmax), rendering the catalytic rate independent of

fluctuating substrate concentration and dependent only on the functional enzyme

concentration present in the patient's specimen. In a clinical laboratory setting,

these kinetic transformations are detected using advanced spectrophotometric,

fluorometric, or chemiluminescent platforms. Continuous-monitoring or kinetic

spectrophotometric assays measure changes in absorbance over a precise time

7
 window. This is achieved by utilizing the specific millimolar extinction

coefficients of coenzymes or reaction colorimeters, such as the reduction of

NAD+ to NADH at a wavelength of 340 nm. The quantification relies on the

Beer-Lambert Law, which establishes a linear relationship between absorbance

(A) and solute concentration (c): A = the molar absorptivity coefficient, C is the

concentration of the absorbing solute, and l represents the optical path length of

the cuvette (standardized internationally at 1.0 cm). By tracking the change in

absorbance per minute, automated analyzers compute the exact enzymatic

activity using the following equation: {Enzyme Activity (U/L)} =

6
( ΔA /min× V − total ͯ × 10 )
, Where V_total is the total volume of the reaction
(ε ×1 ×V sample )

mixture, V_sample is the patient serum volume, and 10^6 converts moles to

micromoles to express activity in International Units per Liter (U/L). One

International Unit (U) is defined as the amount of enzyme that catalyzes the

transformation of 1.0 micromole of substrate per minute under optimal,

standardized conditions of temperature (37°C), pH, and ionic strength. Through

these precise measurements, clinical biochemists can quantify functional enzyme

units, yielding diagnostic data that can point toward cellular or tissue pathologies

before morphological changes are detectable by standard anatomical imaging.

Furthermore, clinical chemists must meticulously control for confounding

analytical variables that interfere with zero-order kinetics.

These parameters include:

● Thermal Fluctuations: Enzymatic activity is highly sensitive to temperature

variations. A 1°C deviation can cause up to a 10% shift in kinetic velocity due to

changes in structural protein conformation and molecular collision frequencies.

8
● Hydrogen Ion Concentration (pH): Extreme pH shifts alter the ionization states

of amino acid residues located within the catalytic triad or binding pocket of the

active site, disrupting substrate binding and denaturing the tertiary structure of the

protein.

● Competitive and Non-competitive Inhibitors: Endogenous heavy metals,

structural drug metabolites, or high concentrations of reaction products can cause

systemic deviations from true zero-order velocity curves.

2.2 Diagnostics Enzymes and Tissue Specificity:

 Diagnostic enzymes: They are biological molecules, typically protein, that

catalyze specific chemical reaction, allowing for the detection or quantification of

particular substances in biological samples. They are crucial in medical diagnosis,

enabling healthcare professionals to identify diseases, monitor treatment efficacy,

and track disease [Link] diagnostic value of clinical enzymology is

enhanced by the concept of tissue specificity and the distribution of specific

enzyme isoforms across organs. While certain metabolic enzymes are

ubiquitously expressed to sustain basal cellular respiration, others are strictly

confined to Specific cellular lineages, structural topologies, or distinct subcellular

compartments. Diagnostics enzymes are a cornerstone of modern clinical

medicine. understanding how these enzymes function is essential for grasping

how clinicians detect and monitor various medical conditions.

Diagnostic enzymes are classified into the following:

1) Enzymes as Biomarkers (indicators of disease): These are enzymes naturally

present in body tissues. Under normal conditions, their levels in the blood

remains stable and low. However, when specific organs or tissues are damaged or

9
 diseased, these enzymes "leak" into the bloodstream, causing their concentrations

to rise significantly.

 Mechanism: Tissue damage increases cell membrane permeability or causes cell

death, releasing intracelular enzymes into the circulation.

 Clinical value: Measuring these allows doctors to

Example of Diagnostic Enzymes

Enzymes Primary Diagnostics use

Creatine Kinase (CK-MB) Myocardial infection (heart attack).

Alanine Transaminase (ALT) Liver damage (highly specific).

Aspartate transaminase (AST) Liver, heart, and muscle damage.

Amylase / Lypase Acute pancreatitis.

Alkaline Phosphatase (ALP) Bone diseases and bile duct obstruction

2) Enzyme as Analytical Tools (Diagnostic Reagents): In this role, enzymes are

not being measured themselves ; rather, they are used as "chemical tools" in the

laboratory to measure other substance in a patients sample (like blood or urine).

 Mechanism: The enzyme is added to a patient sample to catalyze a specific

reaction with a target molecule (e.e., glucose). The speed or outcome of this

reaction is then measured (often via color change or electrical signal), which

is proportional to the concentration of the target molecule.

 Clinical Value: Highly specific and rap;id detection of metabolites,

hormones, and drugs.

Examples of Enzymes as Analytical Reagents

10
 ENZYMES DIAGNOSTIC USES

Glucose Oxidase To measure blood glucose levels in

diabetic patients.

Cholesterol Oxidase To measure total cholesterol levels.

Urease To determine urea levels, help assess

kidney function.

Prostate-specific Antigen (PSA) Prostate cancer screening.

3) Isoenzymes: Isoenzymes are structural variants of an enzyme that catalyze

identical chemical reactions but possess distinct amino acid sequences, kinetic

parameters, and electrophoretic mobilities. For instance, Creatine Kinase (CK) a

critical enzyme that maintains cellular energy homeostasis by reversibly

transferring a high-energy phosphate group from phosphocreatine to adenosine

diphosphate (ADP)—exists as a dimeric protein composed of two distinct sub-

units: M (muscle-derived) and B (brain-derived). These combine to form three

unique tissue-specific isoenzymes: This is a crucial aspect of diagnostic

enzymology .

Examples and diagnostics uses of isoenzymes:

Isoenzyme Subunit Composition Major Tissue Clinical Utility &

Localization Diagnostic

Significance

CK-1 CK-BB Central Nervous Elevated in

System, Blood-Brain cerebrovascular

Barrier, Smooth Muscle accidents (strokes),

brain trauma, and

11
Isoenzyme Subunit Composition Major Tissue Clinical Utility &

Localization Diagnostic

Significance

certain tumors.

CK-2 CK-MB Myocardium (Cardiac Key marker for Acute

Muscle Tissue) Myocardial Infarction

(AMI); elevates 4–6

hours post-injury.

Skeletal Muscle, Elevated in

Myocardium rhabdomyolysis,

CK-3 CK-MM muscular dystrophy,

and intense physical

trauma.

 Methods of Diagnostic enzymes ASSAY:

i. Spectrophotometry: Measures the change in the light absorbance as an

enzyme coverts a substrate into product over time.

ii. ELISA (Enzyme-Linked Immunosorbent Assay): Uses antibody to capture

specific enzyme or proteins, providing high sensitivity for diagnostic testing.

iii. Immunoassays: Utilizes antibodies to detect specific enzymes or substrates.

 Limitations :

i. Specificity : Some enzymes are found in multiple tissues (e.g., AST), which

can sometimes make it difficult to determine the exact source of damage.

12
 ii. Clearance rates: Different enzymes have different half-lives in the blood. If

a test is performed too early or late after injury, an enzyme level might

appear normal even if significant damage occurred.

iii. Interference: Hemolysis (rupture of red blood cells during sample

collection) can artificially inflate the level of many enzymes, leading to false

results.

 TISSUE SPECIFICITY: This is the fundamental concept in biology and

medicine, referring to the phenomenon where certain biological molecules, such

as enzymes, proteins, or gene preferential or exclusive expression in specific

tissue or cell type within on organism. This selective expression is crucial for

enabling tissues to perform unique functions, respond to signals, or maintain

homeostasis, and is a key factor in the development and maintenance of complex

multicellular organisms. When tissue injury occurs, the pattern of released

enzymes serves as an indicator, allowing clinical biochemists to map serum

profiles to corresponding cellular [Link] clinical interpretation of these

profiles relies on understanding whether an enzyme is classified as an absolute

tissue-specific marker or a multi-isoform diagnostic enzyme distributed across

multiple organ groups. Furthermore, structural tissue specificity is often refined

through the analysis of distinct isoenzymes. By executing automated

immunoassays or electrophoretic separation of these distinct isoforms, the clinical

biochemistry laboratory can isolate and identify cellular damage in specific organ

systems, minimizing cross-diagnostic interference. On a standard electrophoretic

support medium (such as agarose gel or cellulose acetate) at an alkaline pH of

8.6, the net negative charge of the subunits dictates their migration toward the

13
 anode (+). Due to the highly acidic nature of the B-subunit, CK-BB migrates the

fastest toward the anode, followed sequentially by the hybrid CK-MB, while the

basic CK-MM remains closest to the cathode (-). This physical separation enables

precise densitometric tracing and structural quantification of the individual

isoenzyme fractions.

2.3 Clinical Correlation with Pathological Conditions

The analytical findings generated by diagnostic enzyme assays are interpreted

alongside established clinical correlation models to map metabolic and structural

pathobiologies. When an organ undergoes hypoxic stress, mechanical trauma, or

chemical toxicity, the homeostatic production of adenosine triphosphate (ATP) via

oxidative phosphorylation is disrupted. The failure of cellular respiration impairs

active transport networks, including the Sodium-Potassium Adenosine Triphosphatase

(Na+ K+ ATPase) pump. This failure leads to an unregulated influx of water and

extracellular ions, inducing cellular swelling, localized membrane blebbing, and

subsequent structural lesions in the phospholipid bilayer. Intracellular enzymes escape

into the interstitial spaces and enter circulation, where they are quantified as

biomarkers of disease.

2.3.1 Myocardial Pathologies and Ischemic Cascades

In acute myocardial infarction (AMI), cardiac muscle cells suffer severe ischemic

necrosis due to coronary artery occlusion. The blockage of coronary arterial blood

flow terminates the supply of molecular oxygen and glucose to the myocardium.

Deprived of oxygen, hepatocytes and cardiomyocytes shift from highly efficient

aerobic oxidative phosphorylation to anaerobic glycolysis. This metabolic shift

generates a low net yield of ATP (only 2 moles of ATP per mole of glucose,

14
compared to 36–38 moles under aerobic conditions) and causes a rapid accumulation

of intracellular lactic [Link] subsequent fall in intracellular pH activates lysosomal

acid hydrolases, which begin to degrade structural cellular components. As ATP

reserves deplete, the Na+/K+ ATPase pump fails, leading to an intracellular influx of

sodium and water, cellular swelling, and the mechanical rupture of the sarcolemma.

Within 4 to 6 hours of an ischemic episode, the highly specific myocardial isoenzyme

CK-MB escapes through the compromised cell membranes, peaking in circulation

within 24 hours. Concurrently, Lactate Dehydrogenase (LDH) activity rises,

exhibiting an inversion of its standard isoenzyme distribution. LDH is a tetrameric

enzyme composed of two distinct polypeptide subunits: H (heart) and M (muscle).

These subunits combine to form five separate isoenzymes (LDH1 to LDH5). Under

normal physiological conditions, the serum concentration of the LDH_2 (H_3M_1)

isoform exceeds that of the heart-specific LDH1 (H4) isoform. However, myocardial

necrosis causes a substantial release of LDH_1, resulting in a pathological LDH flip

(LDH1 > LDH2). This inversion serves as a reliable confirmatory biochemical

indicator for delayed myocardial injury diagnostics, typically appearing 24 to 48

hours post-infarction and persisting for up to a week.

2.3.2 Hepatic Parenchymal and Biliary Pathologies

Similarly, the clinical biochemical profiling of hepatic pathologies relies heavily on

mapping enzyme distribution patterns. Acute viral hepatitis (induced by Hepatitis A,

B, or C viruses) and toxic chemical insults (such as paracetamol overdose) induce

rapid hepatocyte cytolysis. In paracetamol toxicity, the Cytochrome P450 enzyme

system (CYP2E1) metabolizes excess acetaminophen into a highly reactive, toxic

intermediate known as N-acetyl-p-benzoquinone imine (NAPQI). Under standard

conditions, NAPQI is rapidly detoxified via conjugation with intracellular glutathione.

15
However, an overdose depletes glutathione reserves, allowing free NAPQI to bind

covalently to hepatocyte mitochondrial proteins. This induces oxidative stress,

opening the mitochondrial permeability transition pore, causing ATP depletion, and

triggering rapid hepatocyte cytolysis. This destruction results in an exponential rise in

serum ALT and AST levels, often exceeding normal reference ranges by multiple

orders of magnitude (frequently surpassing 1,000 U/L). Conversely, chronic

conditions like hepatic cirrhosis or non-alcoholic fatty liver disease (NAFLD) present

with modest, sustained transaminase elevations (typically 2 to 5 times the upper limit

of normal), reflecting a slower, continuous cycle of cellular death and fibrotic

[Link] the pathological mechanism shifts from parenchymal necrosis to

mechanical cholestasis (bile duct obstruction), the laboratory observes a distinct

change in the serum enzyme profile. Cholestasis can be extrahepatic (caused by

gallstones or a tumor obstructing the common bile duct) or intrahepatic (induced by

drugs or primary biliary cholangitis). In these scenarios, transaminases like ALT and

AST exhibit only mild to moderate elevations. Instead, the laboratory observes a

significant rise in membrane-bound enzymes, specifically Alkaline Phosphatase

(ALP) and Gamma-Glutamyl Transferase (GGT). ALP is bound to the canalicular

membrane of hepatocytes via a glycosylphosphatidylinositol anchor, while GGT is a

membrane-bound enzyme that catalyzes the transfer of \gamma-glutamyl moieties to

amino acids and peptides across cell membranes. When bile flow is obstructed, the

accumulation of detergent-like bile acids dissolves the local cell membrane structures

and stimulates hepatocytes to synthesize ALP and GGT at increased rates. The co-

elevation of both enzymes confirms a biliary origin. Because ALP is also highly

expressed in osteoblasts during bone remodeling, an isolated elevation of ALP could

point to bone pathologies (such as Paget's disease or osteomalacia). However, if GGT

16
is simultaneously elevated, it confirms that the source of the pathology is hepatic or

biliary, demonstrating how diagnostic enzyme profiles can differentiate between

structural cellular necrosis and obstructive biliary tract diseases.

To isolate these diagnostic serum matrices, raw whole-blood samples gathered from

clinical wards must undergo rapid phase separation before the initiation of any kinetic

testing.

2.3.3 Pancreatic Pathologies and Digestive Enzyme Dysregulation

To expand the diagnostic scope of chemical pathology, acute pancreatitis serves as an

excellent model of cellular self-digestion. Acute pancreatitis is characterized by

premature, intracellular activation of digestive zymogens within the pancreatic acinar

cells. Under physiological conditions, digestive enzymes are synthesized as inactive

precursors (such as trypsinogen) and sequestered within zymogen granules. They are

safely transported to the duodenum, where enterokinase converts trypsinogen into

active trypsin, which subsequently activates other zymogens like chymotrypsinogen

and [Link] pathological states—often triggered by gallstone

migration blocking the ampulla of Vater, or chronic alcohol abuse—the fusion of

zymogen granules with lysosomal vacuoles occurs prematurely within acinar cells.

Lysosomal cathepsin B activates trypsinogen to trypsin within the cell. This active

trypsin initiates an autodigestive cascade, activating enzymes that destroy the

pancreatic parenchyma and disrupt surrounding blood [Link] structural

breakdown leads to the rapid release of pancreatic digestive enzymes into the

interstitial space and systemic circulation. The two primary biomarkers quantified in

serum are α-Amylase and Pancreatic Lipase:

17
  Serum α-Amylase: Breaks down starch and glycogen into maltose and

oligosaccharides. In acute pancreatitis, serum amylase levels rise within 2 to 12

hours of onset, peaking at 4 to 6 times the upper reference limit. However,

amylase has a short half-life (approximately 10 to 12 hours) because it is

cleared by the kidneys. Its levels often return to baseline within 3 to 5 days,

making it less useful for delayed presentations. Furthermore, salivary glands

also secrete amylase, meaning elevations can occur in mumps or sialadenitis

unless pancreatic-specific isoamylase testing is utilized.

 Serum Lipase: Hydrolyzes dietary triglycerides into fatty acids and glycerol.

Lipase provides higher clinical specificity and sensitivity for acute pancreatitis.

It rises concurrently with amylase (within 4 to 8 hours) but remains elevated for

8 to 14 days due to its slower renal clearance and resistance to structural

[Link] the relative ratio of these enzymes alongside

transaminases, ALP, and GGT allows clinical biochemists to map multi-organ

involvement and differentiate between primary pancreatic conditions and

secondary hepatobiliary diseases.

Summary of Diagnostic Enzyme Panel Configurations;

To synthesize these clinical correlations into an actionable laboratory framework, the

chemical pathology suite organizes diagnostic enzyme profiles into structured

diagnostic panels. This systematic approach ensures that clinical biochemists can

evaluate structural and metabolic pathologies across multiple organ systems:

● Hepatocellular Core Panel: Consists of ALT and AST. A high elevation

points toward acute viral, toxic, or ischemic parenchymal necrosis.

18
 ● Biliary Obstruction/Cholestatic Panel: Consists of ALP and GGT.

Simultaneous elevations point toward mechanical bile duct blockage or

canalicular membrane irritation.

● Myocardial Infarction Panel: Consists of CK-MB and an LDH_1/LDH_2

evaluation. It tracks structural necrosis of the sarcolemma following ischemic

cascades.

● Pancreatic Autodigestion Panel: Consists of \alpha-Amylase and Lipase. It

tracks acinar cell injury and zymogen leakage during acute inflammatory crises.

Through these comprehensive panels, diagnostic enzymology provides critical

physiological data, enabling precise clinical assessments that support effective

disease management and patient care.

CHAPTER THREE: THE INFECTION PREVENTION UNIT

& CORE ACTIVITIE

3.1 Introduction to Infection Prevention and Control (IPC):

The Infection Prevention and Control (IPC) constitutes an evidence-based,

scientifically rigorous sub-discipline within clinical medicine and public health

administration. Its fundamental mandate is the prevention of healthcare-associated

infections (HAIs) and the containment of antimicrobial resistance (AMR) within

clinical ecosystems. From a structural perspectives, nosocomial environments serve as

major vectors for biological amplification, where high densities of compromised hosts

and a diverse array of virulent pathogens intersect. Consequently, the operational

activities of the IPC unit are targeted at disrupting the well-established "chain of

infection." This clinical chain comprises six specific links: the infectious agent, the

reservoir, the portal of exit, the mode of transmission, the portal of entry, and the

19
susceptible host. By implementing robust biochemical barriers and pharmaceutical

sanitization standards, the IPC unit effectively neutralizes biological agents before

transmission can manifest. For a clinical biochemist, the IPC unit represents far more

than an administrative or regulatory department. It serves as a practical, molecular

arena where advanced chemical formulations are applied to disrupt the lifecycle and

structural survival of pathogenic microorganisms. The physical integrity of bacteria,

viruses, fungi, and endospores relies entirely on the precise maintenance of

macromolecular structures, including phospholipid bilayers, peptidoglycan matrices,

capsid geometries, and active catalytic proteins. The utilization of chemical

formulations in clinical hygiene leverages thermodynamic principles and

thermodynamic instability to systematically destroy these microstructural

architectures. Therefore, an integration of biochemical kinetics, stoichiometry, and

material safety data is necessary to formulate agents capable of providing broad

spectrum microbicidal efficacy while preserving the biological and mechanical

integrity of hospital personnel and clinical hardware.

During the six-month Student Industrial Work Experience Scheme (SIWES)

placement, the core activities executed within the IPC unit involved a dual approach

combining theoretical molecular hygiene with industrial scale compounding.

Biological agents encountered in clinical settings exhibit diverse defense mechanisms,

ranging from the thick lipopolysaccharide outer membranes of Gram-negative

pathogens to the dense cross-linked peptidoglycan cell walls of Gram-positive

organisms. Furthermore, the extreme resistance of bacterial endospores poses a

severe clinical challenge. Mitigating these hazards required an advanced operational

knowledge of structural biochemistry, thermodynamics, and fluid dynamics. This

knowledge was essential for optimizing the shelf-life, stability, and chemical biocidal

20
efficiency of every compounded sanitation agent deployed throughout the hospital

wards, surgical suites, and diagnostic units.

3.2 Biochemistry of Hygiene and formulation Science

The operational efficacy of hygiene formulations depends entirely on the

fundamental laws of chemical interactions and macromolecular thermodynamics.

Foremost among these chemical mechanisms is the action of surface-active agents,

commonly designated as surfactants. Surfactants are amphiphilic organic compounds

possessing dual chemical topologies within a single molecular entity: a distinct

hydrophilic (water-loving, polar)head group and an elongated hydrophobic (water-

fearing, non-polar, lipophilic) hydrocarbon tail. When introduced into an aqueous

environment, these molecules disrupt the cohesive hydrogen-bonding network of

water molecules, drastically decreasing the surface tension of the solvent. This

biochemical property exponentially increases the wetting and penetrating capacity of

the solution, allowing it to access sub-microscopic crevices on contaminated surfaces.

At a critical threshold known as the Critical Micelle Concentration (CMC),

individual surfactant monomers undergo a thermodynamically driven self-assembly

process to form spherical aggregates termed micelles. In these structures, the

lipophilic hydrocarbon tails sequester inward to avoid thermodynamic conflict with

the aqueous phase, while the polar heads project outward into the solvent. When these

micelles contact a biological contaminant, their hydrophobic interiors partition into

the lipid bilayers of enveloped viruses (such as the influenza virus and retroviruses)

and the plasma membranes of bacterial pathogens. This molecular interpolation

induces severe mechanical tension across the fluid mosaic membrane, leading to

immediate solubilization, mechanical fragmentation, and the entrapment of lipophilic

21
debris within the micellar core, allowing them to be rinsed away during

emulsification. Concurrently, chemical agents utilize the mechanism of irreversible

protein denaturation to achieve microbicidal inactivation. The biological function of

bacterial enzymes and viral structural proteins is strictly dictated by their tertiary and

quaternary conformational geometries, which are maintained by a delicate balance of

non-covalent interactions, including hydrogen bonds, electrostatic interactions,

hydrophobic packing, and covalent disulfide bridges. Hygiene formulations

containing highly polar solvents, phenolic derivatives, or strong oxidizing agents

disrupt this structural equilibrium. By competing for hydrogen-bonding sites and

modifying the local dielectric constant of the solvent, these chemicals induce the

cooperative unfolding of the polypeptide chains. The loss of three-dimensional

structure exposes buried hydrophobic residues to the aqueous phase, triggering

immediate aggregation and irreversible precipitation of the proteins, which

deactivates the metabolic machinery of the pathogen.

Furthermore, membrane permeabilization represents a key lethal pathway for

advanced clinical disinfectants. The cell walls and plasma membranes of prokaryotic

organisms function as semi-permeable metabolic barriers that strictly regulate the

electrochemical gradient of the cell, primarily the proton motive force required for

adenosine triphosphate (ATP) synthesis. Chemical formulations containing lipophilic

terpenes or phenolic compounds intercalate into the closely packed core of the

membrane, altering its fluidity and structural integrity. This structural disruption

creates functional pores that allow the unregulated leakage of vital intracellular

metabolites, including potassium ions (K), adenine nucleotides, and metabolic

enzymes. This complete breakdown of homeostatic osmotic balance leads to cell

22
death via immediate osmotic lysis, ensuring the rapid decontamination of clinical

environments.

3.3 Production Procedure and Formulations:

3.3.1 Hand Wash Production: Hand wash preparation involves enzyme-catalyzed

hydrolysis of triglycerides (fats and oil) to produce glycerol and fatty acid salt (soap).

The synthesis of clinical-grade liquid hand wash involves a precise multi-component

formulation designed to optimize lipid emulsification while protecting cutaneous cell

membranes this process is called Saponification, it involves the hydrolysis of

triglycerides with an alkaline substance (usually Sodium Hydroxide, NaOH.).

Reagents used and their respective biochemical roles are defined as follows;

i. Nitrosol / Antisol (Hydroxyethyl Cellulose): Functions as a polymeric viscosity

modifier and stabilizing agent, building a pseudoplastic matrix that suspends

other solutes uniformly throughout the solvent.

ii. Sulphonic Acid (Linear Alkylbenzene Sulfonic Acid): Serves as the primary

anionic surfactant, generating a high charge density that interacts strongly with

lipophilic proteins and foreign matter.

iii. Texapon (Sodium Laureth Sulfate - SLES): Acts as a secondary high-foaming

surfactant and emulsifier, providing excellent stability across varying water

hardness levels.

iv. Caustic Soda (Sodium Hydroxide - NaOH): A strong inorganic base added to

achieve chemical neutralization, driving the saponification equilibrium and

converting raw acids into soluble salts.

23
v. Soda Ash (Sodium Carbonate - Na2CO3) : Functions as a chemical builder and

alkaline buffer, maintaining an optimal pH to enhance detergent efficiency.

vi. Glycerine (Glycerol): An organic triol that serves as a humectant, forming

hydrogen bonds with water molecules to slow evaporation and prevent skin

dehydration.

vii. Color and Fragrance: Additives for sensory optimization and tracking during

ward application.

PROCEDURES:

i. First, Antisol was slowly dissolved in a 40 liters of deionized water with

continuous, unidirectional mechanical agitation. This step is critical to prevent the

formation of highly viscous, semi-hydrated polymer aggregates that inhibit

uniform mixing.

ii. Caustic Soda and Soda Ash were dissolved in water to initiate exothermic

solvation.

iii. Once the solution above cooled, it swas slowly introduced into the hydrated

Antisol polymer base to initialize the structural carrier.

iv. Concurrently, Sulphonic Acid and Texapon were mixed until homogeneous, and

then slowly added to the main vessel, driving an immediate chemical

neutralization reaction. As the reaction approached completion, the mixture

transformed into a highly uniform, translucent gel.

v. Glycerine was then incorporated to stabilize the emollient properties of the

formulation.

vi. Finally, the selected industrial fragrance and water-soluble coloring agents were

dissolved in minimal quantity of water and blended thoroughly into the batch.

The completed solution was allowed to rest for 24 hours to ensure complete gas

24
 disengagement and polymer strand relaxation, resulting in a premium, stable, and

ready-to-deploy clinical liquid hand wash.

Equation of the reaction:

Triglyceride + 3NaOH → Glycerol +3Fatty acid salt (soap).

3.3.2 Disinfectant (Bleach) Production : Bleach (Sodium hypochlorite, NaOCl) is

typically prepared through the reaction of chlorine gas (Cl2) with sodium hydroxide

(NaOH) The production of heavy-duty hospital disinfectants focuses on maximizing

microbicidal efficacy against highly resistant nosocomial pathogens, including

Pseudomonas aeruginosa and Staphylococcus aureus.

Reagents and their biological respective biochemical roles are defined as

follows:

1) Texapon (SLES): Functions as a non-ionic/anionic co-surfactant and primary

carrier phase.

2) Pine Oil (Terpinol Extractive):The primary natural antimicrobial agent,

emulsifier, essential for solubilizing highly lipophilic organic oils within an

aqueous rich in cyclic terpene alcohols that easily penetrate the thick lipid

membranes of pathogenic bacteria.

3) Phenol / Lysol (Hydroxybenzene derivatives): Highly active chemical

disinfectants that denature proteins and disrupt cell walls, even in the presence of

organic matter like blood or exudates.

4) Chloroxylenol (4-chloro-3,5-dimethylphenol): A broad-spectrum antimicrobial

chemical compound that targets microbial cell walls and deactivates essential

metabolic enzymes.

25
5) Water:serves as the universal polar solvent matrix.

Equation of the reaction:

Cl2 + 2NaOH → NaOCl +Nacl + H2O

Procedures:

The formulation protocol requires precise execution to ensure complete chemical

emulsification, as phase separation would cause localized under-dosing.

1. First, Texapon was measured into a chemical-resistant blending tank, and

2. Pine Oil was added progressively while maintaining constant agitation. This stage

creates a concentrated micro-emulsion wherein the hydrophobic pine oil is

trapped within the cores of the Texapon surfactants.

3. Phenol and Lysol were introduced to the mixture under a fume hood to protect

the operator from volatile chemical vapors.

4. Chloroxylenol was added to the hydrophobic core to optimize broad-spectrum

bactericidal properties.

5. Once the active organic phase achieved complete homogeneity, deionized water

was slowly introduced into the vortex. This triggers an immediate phase

inversion, transforming the clear organic mixture into a milky-white, highly

stable macro-emulsion. This structured fluid remains stable under prolonged

storage and rapidly releases its active microbicidal components upon surface

application.

3.3.3 Room Freshener Production: Hospital environmental management requires

the neutralization of volatile organic compounds and odors associated with biological

26
decay and metabolic waste. The room freshener formulation utilizes precise chemical

carriers to facilitate aerosolization and control evaporation rates:

Reagents used and their function includes :

i. Ethanol (C2H5OH): Functions as a highly volatile solvent carrier, characterized

by low boiling points and low surface tension, allowing for rapid vaporization

without leaving structural residues.

ii. Industrial Fragrance Concentrates: Synthesized ester- and terpene-rich oils

engineered to chemically mask odors and refresh clinical environments.

iii. Fixative (Diethyl Phthalate): High-boiling-point chemical anchors that form

weak intermolecular associations with volatile fragrance molecules, extending

their presence in the room air.

PROCEDURE:

i. First, industrial fragrance concentrate was combined with the chemical fixative in

an anhydrous mixing vessel. This step allows the fixative to bind the volatile

components via non-covalent interactions.

ii. In a separate vessel, the volatile solvent carrier (typically absolute ethanol or

deodorized hydrocarbon) was measured and added to the fragrance mixture.

iii. The system was sealed to prevent the evaporation of volatile components and

subjected to high-shear mechanical agitation until complete dissolution occurred.

This process yielded a clear, single-phase solution that nebulizes efficiently upon

aerosolization, ensuring an immediate and lasting improvement in indoor air quality.

3.3.4 Hand sanitizer: Hand sanitizers, specifically those recommended for

efficacy against enveloped viruses and a broad spectrum of bacteria, rely on the

27
biochemical disruption of cellular structures. The following document outlines the

scientific rationale and standardized procedure for producing a World Health

Organization (WHO) recommended formulation.

 Biochemical Rationale and Mechanism

The primary active ingredient in effective hand sanitizer is a short-chain alcohol,

typically Ethanol (C2H5OH) or Isopropanol.

Mechanism of Action

● Protein Denaturation: Ethanol acts as a solvent that penetrates the lipid-rich

cell membranes of microorganisms. Upon entry, it disrupts the secondary and

tertiary structures of proteins and enzymes through the breaking of hydrogen

bonds. This causes rapid denaturation and subsequent loss of function, leading

to cell death.

● Membrane Disruption: By interacting with the lipid bilayer of enveloped

viruses (such as SARS-CoV-2) and bacterial cell walls, the alcohol increases

membrane fluidity and permeability, leading to the leakage of intracellular

components and eventual lysis.

● Optimal Concentration: The biochemical efficacy peaks between 60% and

80% (v/v). At these concentrations, the presence of water is crucial; water acts

as a polar catalyst, facilitating the penetration of the alcohol through the cell

wall and slowing its evaporation, thereby increasing the contact time required

for denaturation.

Materials and Reagents.

i. Ethanol (C2H5OH): Active antimicrobial agent (denaturant)

28
 ii. Hydrogen Peroxide (H2O2): Sporicidal agent to neutralize microbial

contamination in the bulk liquid.

iii. Glycerol: Humectant; protects skin and prevents evaporation.

iv. Sterile Distilled/Boiled Water.

Production Procedure.

1. Preparation and Sanitization

 Environment: The production must take place in a clean, dust-free environment.

All mixing vessels (glass or high-density plastic) must be sterilized before use.

 Safety: Ensure adequate ventilation. Ethanol is volatile and highly flammable;

maintain distance from open flames or spark sources.

2. Mixing Sequence

● Dispensing Ethanol: Ethanol was poured into the primary mixing vessel.

● Hydrogen Peroxide H2O2 was added to the ethanol. Note: Hydrogen peroxide

is added to eliminate potential spore-forming bacteria in the containers; it is

not the active ingredient for hand disinfection.

● Incorporating Glycerol: was added. Since glycerol is highly viscous, rinse the

measuring vessel with the distilled water to ensure the full quantity is

transferred.

● Dilution: A specific quantity of water was added

● Homogenization: The container was sealed immediately to prevent the

evaporation of the volatile [Link] the mixture was stirred vigorously for

2–3 minutes to ensure total homogenization of the solutes.

29
 Biochemical Safety and Storage

● Flammability: The high concentration of ethanol makes the product a Class 3

flammable liquid. Storage must be in cool, dry areas away from ignition

sources.

● Stability: Keep containers tightly closed. Ethanol’s high vapor pressure means

that any leak will lead to a rapid decrease in the active concentration, rendering

the sanitizer ineffective.

● Regulatory Compliance: Any production for public distribution should adhere

to the WHO Guidelines on Hand Hygiene in Health Care to ensure safety and

standardization.

3.4 Quality Control and Safety Metrics in Formulation:

To ensure that all manufactured hygiene products meet the rigorous requirements of a

clinical environment, strict quality control (QC) and analytics were conducted on

every batch. The primary metric evaluated was the pH profile of the liquid soap

formulations, measured using a calibrated digital pH meter. Given that human skin

maintains an acidic mantle (pH 5.5 - 6.5) to inhibit opportunistic pathogen

colonization, any hand wash formulation must balance clinical efficacy with

dermatological safety, falling within an acceptable range of pH 6.5 - 7.5. An elevated

pH indicates an incomplete neutralization reaction and residual caustic soda, which

would cause chemical dermatitis, protein hydrolysis, and skin irritation in healthcare

workers. The neutralization reaction is governed by the following relationship: R-

SO3H + NaOH →R-SO3Na + H2O Viscosity and physical stability monitoring were

performed by subjecting random batch samples to accelerated thermal stress tests.

This involved monitoring the formulations across temperatures ranging from 4ºC to

30
45ºC over a 72 hour period. Any instance of phase separation, flocculation, or

precipitation indicated a structural failure in surfactant packing or polymer hydration,

leading to rejection of the batch. For heavy-duty disinfectants, concentration accuracy

was verified to confirm that active chloroxylenol or phenolic compounds met clinical

microbicidal thresholds. Under-concentrated solutions fail to completely eliminate

resilient bacterial strains, contributing to the development of antimicrobial resistance,

while over-concentrated mixtures present toxic, corrosive hazards to patient

respiratory tracts.

Finally, industrial safety metrics during production were strictly enforced. Due

to the dangerous nature of concentrated raw materials, including caustic soda and

sulfonic acid, all compounding procedures required personal protective equipment

(PPE). This included heavy-duty nitrile chemical gloves, high-impact polycarbonate

goggles, fluid-resistant laboratory coats, and respiratory masks with organic vapor

filters. Spills or runaway exothermic reactions were managed using neutralizing sand

banks and chemical sorbents. Through these precise chemical controls and safety

measures, the IPC unit successfully manufactured high-efficiency hygiene

formulations that maintained a sterile clinical environment.

CHAPTER FOUR EXPERIENCES AND CHALLENGES

4.1 Experience and Practical Knowledge Acquired

The industrial training period provided intensive practical experience in the clinical

pathology laboratory, bridging the gap between theoretical metabolic pathways and

diagnostic biochemistry. Hands-on experience was gained in the handling, processing,

and analysis of biological specimens, focusing on how cellular pathologies manifest

as quantifiable changes in serum chemistry.

31
 Pre-Analytical Processing and Specimen Integrity

A critical competency acquired during the training was mastering pre-analytical

workflows, specifically separating whole blood into its constituent phases. Whole

blood collected in serum separator tubes (SST) containing clot activators and a

specialized silicone gel was processed to isolate serum for enzymatic and metabolic

assays. Biochemically, maintaining specimen integrity is essential to prevent

hemolysis. Hemolysis causes the rupture of erythrocytes, releasing high

concentrations of intracellular components into the serum matrix. For instance,

because erythrocytes contain intracellular concentrations of Aspartate

Aminotransferase (AST) and Lactate Dehydrogenase (LDH) that are significantly

higher than baseline serum levels, even mild hemolysis falsely elevates these

parameters, leading to inaccurate diagnostic interpretations. To achieve optimal phase

separation without causing mechanical lysis, blood samples were balanced and

centrifuged under precise relative centrifugal forces (RCF).

 Manual and Automated Spectrophotometric Assays

Practical proficiency was developed in both manual spectrophotometric

configurations and automated analyzer maintenance. This included preparing working

reagents, calibrating baseline values using standard reference materials, and

troubleshooting kinetic [Link] manual setups, colorimetric assays were performed

using specific light paths to monitor the generation of colored chromogens. For

example, in Alkaline Phosphatase (ALP) assays, the hydrolysis of the colorless

substrate p-nitrophenyl phosphate (p\text{NPP}) to the yellow product p-nitrophenol

was monitored continuously at 405 nm. Understanding the relationship between the

path length (l), the millimolar extinction coefficient, and the rate of change in

absorbance ( Δ A/min) allowed for the calculation of exact enzymatic activity in

32
International Units per Liter (U/L). On automated platforms, experience was gained in

monitoring real-time kinetic curves, validating quality control controls (Levey

Jennings charts), and maintaining automated sample probes to prevent cross-

contamination.

 Hygiene, Sanitation, and Formulation Science

In addition to clinical diagnostics, practical experience extended to the formulation of

hygiene and sanitation products within the Infection Prevention and Control (IPC)

framework. This applied chemical manufacturing included the bulk formulation of

liquid soaps, room fresheners, and surface disinfectants to maintain a sterile hospital

environment and reduce nosocomial infections. Biochemically, liquid soap

formulation relies on a saponification reaction, where long-chain fatty acids

(triglycerides) are hydrolyzed under highly alkaline conditions. Typically, a

concentrated base such as sodium hydroxide (NaOH) for solid soap or potassium

hydroxide (KOH) for liquid soap is reacted with vegetable lipids. This process breaks

the ester bonds of the triglyceride, yielding free glycerol and alkali salts of fatty acids

(amphipathic soap molecules). These amphipathic molecules form spherical micelles

in aqueous environments, with hydrophobic tails capturing lipid-bound dirt and

cellular pathogens, while their hydrophilic heads face outward to allow them to be

washed away with water. Disinfectant formulations required calculating volume-to-

volume percentage dilutions (C1V1 = C2V2) of absolute chemicals like isopropyl

alcohol or sodium hypochlorite (NaOCl). This ensured the final solutions possessed

the correct osmolarity and chemical activity to denature bacterial cell wall proteins

and destabilize lipid envelopes without posing a toxic hazard to healthcare personnel.

33
4.2 Problems and Challenges Encountered During Training

Despite the extensive practical knowledge acquired, several technical and structural

challenges were encountered in the laboratory, affecting operational efficiency and

the continuous flow of diagnostic workflows.

i. Power Outages and Thermal Fluctuations

A primary challenge was intermittent electrical power supply, which directly

disrupted delicate clinical equipment. Because kinetic enzyme assays rely on

maintaining a constant temperature of 37°C within the analyzer's reading block,

sudden power outages caused immediate thermal drops. Biochemically, temperature

variations alter the kinetic energy of reactant molecules and can destabilize the

tertiary structure of enzymes. This disrupts the zero-order kinetic state ([S] \Km),

rendering automated calibration parameters invalid. Power fluctuations also affected

the cold-chain storage of laboratory reagents, controls, and patient [Link]

enzymes and coenzymes (such as NADH and NAD+) outside their optimal storage

temperatures (2°C to 8°C) accelerates their structural denaturation, resulting in a loss

of functional stability and causing a systematic downward bias in patient results.

ii. Reagent Stockouts and Diagnostic Disruptions

Frequent stockouts of vital analytical reagents and calibrators often brought routine

chemical pathology profiles to a halt. When specific enzyme substrates or antibody

conjugates for immunoassays were unavailable, patient samples had to be outsourced

or deferred. From a technical perspective, switching between different manufacturers'

reagent kits due to supply shortages required repeating calibration curves and

recalibrating baseline values. Different diagnostic kits may utilize variations in buffer

34
systems, ionic strengths, or optimal pH settings, which alters the enzyme's Michaelis

constant (Km) and requires extensive validation before patient samples can be

processed.

iii. Mechanical Equipment Breakdown

The high volume of daily diagnostic tests led to frequent mechanical wear and

breakdown of automated components, such as sample pipetting probes and optical

light paths. In automated chemistry systems, stepper motors drive micro-syringes to

deliver precise microliter volumes of sample and reagent into the reaction cuvettes.

Over time, the accumulation of protein residues or mineral deposits can partially

block theseprobes, leading to inaccurate volume delivery. In kinetic assays, a small

reduction in sample volume alters the final ratio of enzyme to substrate, preventing

total substrate saturation and causing underestimations of true serum enzyme activity.

Repair delays due to a shortage of on-site biomedical engineers often required

laboratories to switch back to manual testing methods, which increased processing

times and the potential for human error.

4.3 Recommendations

To improve the training experience for future interns and enhance the quality of

clinical diagnostic services, the following recommendations are proposed:

 For the University and Department

● Pre-Internship Practical Training: The Department of Biochemistry should

expand its laboratory coursework to include hands-on experience with semi-

automated analyzers and advanced pipetting techniques. This would ensure students

35
are familiar with basic clinical laboratory instrumentation before entering their

industrial rotations.

● Curriculum Integration of Clinical Quality Control: The academic curriculum

should explicitly incorporate modules on clinical quality assurance, including the

interpretation of Levey-Jennings charts and Westgard rules. This alignment would

bridge the gap between abstract enzymatic concepts and real-world laboratory data

validation.

 For the SIWES Unit

● Timely Distribution of Logbooks: The SIWES unit should streamline

administrative processing to ensure logbooks and operational guidelines are

distributed to students well before their start dates. This would prevent delays in

documenting daily competencies.

● Regular On-Site Supervision: Faculty supervisors should conduct structured visits

to training sites during the placement period. This would allow for better evaluation of

student progress and help maintain strong partnerships with training institutions.

For the Industrial Training Center (Hospital Laboratory)

● Back-Up Power Infrastructure: The hospital management should install

dedicated,high-capacity Uninterruptible Power Supply (UPS) systems and secondary

solar-inverter arrays for the chemical pathology suite. This would protect sensitive

automated instrumentation from power fluctuations and maintain constant 37°C

incubation blocks.

● Inventory Control Protocols: The laboratory should adopt digital inventory

management systems that track minimum stock levels and automate reorder requests

for reagents. This would minimize diagnostic disruptions caused by supply shortages.

36
● Structured Internal Training Seminars: Senior laboratory scientists should

organize weekly clinical presentations for interns. Discussing the biochemical

mechanisms behind interesting or anomalous patient results would enrich the

educational value of the internship.

4.4 Conclusion

In conclusion, the six-month Student Industrial Work Experience Scheme

(SIWES) placement served as an invaluable bridge between abstract biochemical
theory and the operational realities of professional practice. Through systematic
hands-on rotations within the Clinical Pathology laboratory and the Infection
Prevention and Control (IPC) unit, complex academic paradigms were translated into
practical, life-saving diagnostic and public health workflows. The clinical pathology
phase of the internship successfully demonstrated that the fundamental principles of
thermodynamics and enzyme kinetics taught in the lecture hall are not merely
conceptual models, but the absolute foundation of modern diagnostic medicine.
Evaluating cellular damages and structural pathologies via automated kinetic assays
proved that maintaining zero-order reaction mechanics ([S] Km) is critical for
translating cell membrane permeability into quantifiable clinical data. Mapping organ-
specific enzyme profiles ranging from the transaminase elevations in hepatocellular
necrosis to the structural isoenzyme distributions of Creatine Kinase (CK) in
myocardial infarctions ghlighted the vital diagnostic power of tissue specificity in
managing systemic disease. Simultaneously, the industrial and compounding
chemistry experience gainedwithin the IPC unit broadened my professional
competencies. Transitioning from metabolic pathways to formulation science such as
executing bulk saponification reactions to synthesize liquid hand wash and
performing precise volume-to-volume chemical dilution calculations (C1V1 = 2V2)
for surface disinfectants underlined the multidisciplinary nature of biochemistry. It
reinforced how surfactant mechanics and protein-denaturing agents serve as the
frontline defense against microbial pathogens in a tertiary healthcare facility.

37
Ultimately, navigating the technical and operational challenges of the laboratory
including managing pre-analytical variables like hemolysis, stabilizing thermal
incubation blocks at 37°C during power fluctuations, and calibrating dynamic
baseline values across varying reagent kits matured my clinical judgment and
problem-solving capabilities. This industrial experience has instilled a deep
appreciation for quality control and analytical precision. It firmly establishes that the
biochemist is an indispensable asset within the biomedical ecosystem, uniquely
equipped to decode macroscopic human pathology through the precise lens of
molecular and chemical diagnostics.

38
REFERENCES

● Burtis, C.A. and Bruns, D.E. (2021). Tietz Fundamentals of Clinical Chemistry and

Molecular Diagnostics. 8th edn. St. Louis, MO: Elsevier Saunders. (Provides the

updated clinical biochemistry standards for liver function panels, renal filtration

clearances, and modern spectrophotometric configurations).

● Gaw, A., Murphy, M.J., Srivastava, R. and O'Reilly, D.S. (2022). Clinical

Biochemistry: An Illustrated Colour Text. 6th edn. Edinburgh: Elsevier. (Supports the

structural analysis of cardiac ischemic cascades, the biochemistry of the LDH flip, and

cellular markers of myocardial tissue necrosis).

● Marshall, W.J., Day, A. and Lapsley, M. (2020). Clinical Chemistry. 9th edn.

London: Elsevier Health Sciences. (Details current pre-analytical centrifugation

protocols, relative centrifugal force settings, and strategies to prevent in vitro

hemolysis in sample processing).

● Nelson, D.L. and Cox, M.M. (2021). Lehninger Principles of Biochemistry. 8th edn.

New York: W.H. Freeman and Company. (Provides contemporary derivations of

Michaelis-Menten enzyme kinetics, activation energy thresholds (\Delta G^\ddagger),

and mathematical proofs for zero-order saturation physics ([S] \gg K_m)).

● Rifai, N., Horvath, A.R. and Wittwer, C.T. (2018). Tietz Textbook of Clinical

Chemistry and Molecular Diagnostics. 6th edn. St. Louis, MO: Elsevier. (Essential

reference for high-throughput automated biochemistry analyzers, quality control

validation frameworks, and automated pipetting probing calibrations).

● Soni, S. (2024). Textbook of Medical Biochemistry. 2nd edn. New Delhi: Jaypee

Brothers Medical Publishers. (Supports the biochemical correlation profiles of

paracetamol-induced NAPQI toxicity, acute pancreatitis zymogen cascades, and the

utilization of the De Ritis ratio (AST/ALT)).

39
● Vasudevan, D.M., Sreekumari, S. and Vaidyanathan, K. (2023). Textbook of

Biochemistry for Medical Students. 10th edn. New Delhi: Jaypee Brothers Medical

Publishers. (Provides clinical mapping models for tissue-specific isoenzymes, including

the electrophoretic properties of the CK dimeric isoforms CK-MM, CK-MB, and CK-

BB).

● World Health Organization (2022). Global Guidelines for Infection Prevention and

Control (IPC) Infrastructure. Geneva: World Health Organization. (Supports the

application of clinical hygiene standards, volume-to-volume dilution calculations

(C_1V_1 = C_2V_2), and surfactant micelle requirements for hospital surface

disinfection).

40
APPENDIX

APPENDIX A: CHEMICAL PATHOLOGY LABORATORY REFERENCE

RANGES

The following reference intervals are utilized within the clinical chemical pathology

laboratory for adult serum panels at an analytical incubation temperature of 37°C:

Enzyme Biomarker Abbreviation Standard AdultClinical Pathological

Reference Range Target

Alanine 7 – 56 U/L Hepatocellular Injury /

Aminotransferase ALT Cytolysis

Aspartate 10 – 40 U/L Parenchymal Necrosis /

Aminotransferase AST Deep Tissue Insult

Alkaline Phosphatase Biliary Obstruction /

ALP 44 – 147 U/L Cholestasis

Gamma-Glutamyl 9 – 48 U/L Cholestasis / Alcohol-

Transferase GGT induced Synthesis

Creatine Kinase 55 – 170 U/L Skeletal Muscle /

(Total) CK Myocardial Trauma

Creatine Kinase MB < 25 U/L (or < 5% ofAcute Myocardial

Isoform CK-MB Total CK) Infarction (AMI)

Lactate Tissue Ischemia /

Dehydrogenase LDH 140 – 280 U/L Hemolysis Marker

\alpha-Amylase Amylase Pancreatic Acinar Cell

30 – 110 U/L Inflammation

Pancreatic Lipase Lipase 0 – 160 U/L Acute Pancreatitis

41
Enzyme Biomarker Abbreviation Standard AdultClinical Pathological

Reference Range Target

Autodigestion

APPENDIX B: SURFACTANT AND HYGIENE FORMULATION

MECHANISMS

The mass balance and chemical blending protocols executed during the industrial

training for environmental sanitation products are calculated using standard

percentage concentrations by weight (% w/w) and volume-to-volume dilutions:

1. Liquid Hand Wash Soap Formulation Profile (Base Batch: 50 Liters)

● Active Surfactant / Foaming Agent: Texapon (Sodium Lauryl Ether Sulfate -

SLES) — 3.5 kg

● Viscosity Modifier / Thickening Agent: Sodium Chloride (NaC}) Adjusted

quantum satis (\approx 1.5 kg)

● Foam Booster and Stabilizer: Nitrosol / Antisol (Cellulose derivative) — 0.5

kg

● Emollient / Skin Conditioner: Glycerol — 250 mL

● Antimicrobial Preservative: Formaldehyde alternative / Chloroxylenol -

100mL

● Aromatic and Color Additives: Fragrance oil and water-soluble pigment —

Quantum satis

● Aqueous Medium: Deionized Water (\text{H}_2\text{O}) — Balance to 50 L

42
2. Saponification and Micelle Action Equation

The long-chain alkyl ethoxysulfate structures organize in an aqueous matrix into

spherical aggregates called micelles. These trap non-polar lipid bilayers of viruses and

bacteria within their hydrophobic cores, while their negatively charged hydrophilic

heads face the outer aqueous environment, facilitating mechanical removal during

hand-washing cycles.

APPENDIX C: CHEMICAL DISINFECTANT DILUTION CALCULATIONS

To prepare chlorine-releasing environmental disinfectants from high-concentration

stock solutions (e.g., commercial Sodium Hypochlorite or bleaching powder) for

infection prevention, the working concentrations are calculated via the linear

conservation of mass equation:

C1V1 = C2V2

Where:

1. C1 = Concentration of the stock solution available (\% active chlorine

available)

2. V1 = Volume of the stock solution required ({mL} or {L})

3. C2 = Target concentration of the desired working solution (\% active chlorine

required)

4. V2 = Final target volume of the working solution to be formulated (mL or L)

43